<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01733342</url>
  </required_header>
  <id_info>
    <org_study_id>HP2012-k</org_study_id>
    <nct_id>NCT01733342</nct_id>
  </id_info>
  <brief_title>Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport</brief_title>
  <acronym>SiCDIP</acronym>
  <official_title>Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the performance of domestic chemoport and imported chemoport
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      chemoport implantation was done by two investigator Chemoport type was randomly rendered.
      Domestic chemoport(Human port) and imported chemoport (Celsite) were used. chemoport function
      will be followed up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>function of chemoport</measure>
    <time_frame>6 months</time_frame>
    <description>Whether or not chemoport function is intact will be assessed. Chemoport function will be rendered as intact when chemotherapeutic agent is well infused through the chemoport. Chemoport function will be rendered as not intact when chemotherapeutic agent could be infused through the chemoport.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>infection</measure>
    <time_frame>6 months</time_frame>
    <description>If infection related with chemoport develop during 6 month follow-up, infection will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin dehiscence</measure>
    <time_frame>6 months</time_frame>
    <description>If skin dehiscence related with chemoport develop during 6 month follow-up, it will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>deep vein thrombosis</measure>
    <time_frame>6 months</time_frame>
    <description>If deep vein thrombosis related with chemoport develop during 6 month follow-up, it will be recorded. Deep vein thrombosis can be develop in the jugular vein which is access route.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrin sheath</measure>
    <time_frame>6 months</time_frame>
    <description>If fibrin sheath around chemoport catheter develop during 6 month follow-up, it will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">176</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Celsite</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients received celsite chemoport implantation under local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Humanport</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients received Humanport chemoport implantation under local anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Celsite chemoport implantation</intervention_name>
    <description>Celsite chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance</description>
    <arm_group_label>Celsite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>local anesthesia</intervention_name>
    <description>chemoport implantation will be done under local anesthesia using lidocaine.</description>
    <arm_group_label>Celsite</arm_group_label>
    <arm_group_label>Humanport</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Humanport chemoport implantation</intervention_name>
    <description>Humanport chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance</description>
    <arm_group_label>Humanport</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who will receive chemotherapy via implantable port

          -  age &gt;20 years

          -  expected life time &gt; 6 months

          -  lab test (platelet&gt;50K, PT INR &lt;2.0)

        Exclusion Criteria:

          -  performance status &gt;2

          -  brain metastasis

          -  expected life time less than 6 months

          -  age less than 20 years

          -  active infection

          -  severe heart dysfunction

          -  recent myocardial infarct
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-Cheol Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982 Oct;92(4):706-12.</citation>
    <PMID>7123491</PMID>
  </reference>
  <reference>
    <citation>Ahn SJ, Kim HC, Chung JW, An SB, Yin YH, Jae HJ, Park JH. Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol. 2012 May-Jun;13(3):314-23. doi: 10.3348/kjr.2012.13.3.314. Epub 2012 Apr 17.</citation>
    <PMID>22563269</PMID>
  </reference>
  <reference>
    <citation>Teichgräber UK, Kausche S, Nagel SN, Gebauer B. Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol. 2011 Jun;21(6):1224-32. doi: 10.1007/s00330-010-2045-7. Epub 2011 Jan 5.</citation>
    <PMID>21207035</PMID>
  </reference>
  <reference>
    <citation>Teichgräber UK, Kausche S, Nagel SN. Evaluation of radiologically implanted central venous port systems explanted due to complications. J Vasc Access. 2011 Oct-Dec;12(4):306-12. doi: 10.5301/JVA.2011.7739.</citation>
    <PMID>21534232</PMID>
  </reference>
  <reference>
    <citation>Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998 Jul;9(7):767-73.</citation>
    <PMID>9739444</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2012</study_first_submitted>
  <study_first_submitted_qc>November 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2012</study_first_posted>
  <last_update_submitted>December 2, 2013</last_update_submitted>
  <last_update_submitted_qc>December 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Cheol Kim</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

